MedTrace Logo

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

NCT02018159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 738

Last updated 2017-08-28

No results posted yet for this study

Summary

This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.

Conditions

Interventions

DRUG

menotropin

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-02-12
Completion
2016-05-12

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02018159 on ClinicalTrials.gov